Back to Agenda
Strategic Priorities of the International Coalition of Medicines Regulatory Authorities in an Increasingly Globalized Industry
Session Chair(s)
Ian Hudson
Senior Advisor, Integrated Development, Bill and Melinda Gates Foundation, United States
The International Coalition of Medicines Regulatory Authorities (ICMRA) will explore its strategic priorities in the context of a globalized world. To overcome these challenges ICMRA can champion greater harmonisation and convergence. The session will be delivered by members of ICMRA and conclude with a panel discussion of questions raised by the audience.
Learning Objective : Describe strategic priorities of ICMRA in the context of the globalized world.
Speaker(s)
Guido Rasi, MD
Chairman,Clinical Trial Center of Gemelli Polyclinic Inst; Prof of Microbiology, Tor Vergata University of Rome, Italy
Overview of ICMRA and Strategic Priorities: Including Vigilance, Track, and Trace
Lorraine Nolan, PhD
Chief Executive, Health Products Regulatory Authority , Ireland
The 'Innovation' Priority Project
John Skerritt, PhD
Enterprise Professor, Health Research Impact, University of Melbourne, Australia
Current Topics of Interest to ICMRA Members Including Biosimilars and AMR
Yasuhiro Fujiwara, MD, PhD
Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Panelist
David B. Jefferys, MD, FRCPC
Senior Vice President, EISA EUROPE LTD, United Kingdom
IFPMA View
Have an account?